BioNTech SE - ADR (BNTX) is lower by Friday morning, with the stock losing -2.17% in pre-market trading to 153.52. BNTX's short-term technical score of 44 indicates that the stock has traded less bullishly over the last month than 56% of stocks on the market. In the Biotechnology industry, which ranks 96 out of 146 industries, BioNTech SE - ADR ranks higher than 45% of stocks. BioNTech SE - ADR has risen 21.18% over the past month, closing at $135.62 on October 14. During this period of time, the stock fell as low as $118.43 and as high as $163.34. BNTX has an average analyst recommendation of Buy. The company has an average price target of $216.00.
BNTX has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on BNTX!